Medicare Part D – Page 30 – medicarereport.org

Thursday, January 29, 2026

Latest:

Medicaid Medicare - General Medicare Advantage Medigap Part D/Prescription Drugs

Eileen Cook August 17, 2023August 17, 2023 0 Comments Employer Coverage, Medicaid, medicare, Medicare Advantage, Medicare Part D

A Snapshot of Sources of Coverage Among Medicare Beneficiaries

(By Gabrielle Clerveau, Nancy Ochieng, Juliette Cubanski, and Tricia Neuman for The Kaiser Family Foundation Published: Aug 14, 2023) Medicare

Legislative Update Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook August 17, 2023August 17, 2023 0 Comments Legislation, medicare, Medicare Advantage, Medicare Part D, Prior Authorization, Reducing Medically Unnecessary Delays in Care Act

Another House bill takes aim at prior authorizations

(By Andrew Cass for Becker’s Hospital Review) Maryland Rep. Mark Green has introduced a bill targeting prior authorization requirements in

CMS Health Care Finance Health Care Redesign Part D/Prescription Drugs

Eileen Cook August 16, 2023August 16, 2023 0 Comments CMS, Drug-pricing, Medicare Drug Price Negotiation Program, Medicare Part D

The 10 drugs that CMS might wrangle into negotiations

(By Paige Twenter for Becker’s Hospital Review) CMS plans to soon release its list of 10 drugs that are up

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook August 14, 2023August 14, 2023 0 Comments CMS, Enrollment, Healthcare Costs, medicare, Medicare Advantage, Medicare Part D

Medicare Advantage in 2023: Enrollment Update and Key Trends

(By Nancy Ochieng, Jeannie Fuglesten Biniek, Meredith Freed, Anthony Damico, and Tricia Neuman for the Kaiser Family Foundation Published: Aug

CMS Health Care Finance HHS Medicare Advantage Part D/Prescription Drugs

Eileen Cook August 11, 2023August 11, 2023 0 Comments CMS, Healthcare Costs, medicare, Medicare Advantage, Medicare Part D, Medicare Star Ratings

Medicare Advantage in 2023: Premiums, Out-of-Pocket Limits, Cost Sharing, Supplemental Benefits, Prior Authorization, and Star Ratings

(By Nancy Ochieng, Jeannie Fuglesten Biniek, Meredith Freed, Anthony Damico, and Tricia Neuman for the Kaiser Family Foundation Published: Aug

CMS Health Care Finance Health Care Redesign HHS Legislative Update Medicare - General Part D/Prescription Drugs

Eileen Cook August 9, 2023August 9, 2023 0 Comments CMS, Healthcare Costs, Healthcare Finance, HHS, Inflation Reduction Act of 2022, Medicare Part D

FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program

(By Juliette Cubanski for the Kaiser Family Foundation published August 8, 2023) The Inflation Reduction Act of 2022 (the Act),

Alzheimer's/Dementia Health Care Finance Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook August 2, 2023August 2, 2023 0 Comments Alzheimer's Disease, CMS, Donanemab, Dual Eligible, FDA, Lecanemab Drug, Medicaid, medicare, Medicare Part D, Older Adults

The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers

(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely

CMS Health Care Finance Part D/Prescription Drugs

Eileen Cook August 1, 2023August 1, 2023 0 Comments CMS, Healthcare Costs, medicare, Medicare Part D

CMS projects slightly lower Medicare Part D premiums in 2024

(By Rylee Wilson for Becker’s Hospital Review) CMS is projecting Medicare Part D premiums to decrease by 1.8 percent in

CMS Medicaid Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook August 1, 2023August 1, 2023 0 Comments CMS, Dual-Eligible, medicare, Medicare Advantage, Medicare Part D, Mediciad

How Do Dual-Eligible Individuals Get Their Medicare Coverage?

(By Maria T. Peña, Maiss Mohamed, Jeannie Fuglesten Biniek, Juliette Cubanski, and Tricia Neuman for Kaiser Family Foundation Published: Jul

CMS Health Care Finance Health Care Redesign Medicare - General Part D/Prescription Drugs

Eileen Cook July 28, 2023July 28, 2023 0 Comments Big Pharma, CMS, medicare, Medicare Drug Price Negotiation Program, Medicare Part D

What’s a fair price for a prescription drug? Medicare’s about to weigh in

(By Leslie Walker and Dan Gorenstein for NPR) Drugmakers around the globe are bracing for a major shakeup in how